MR
Maury Raycroft Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
61.5%
Neutral
38.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $63 |
171%
upside
| 1 | +18% |
0
%
| 30 Dec ‘25 9 days ago |
|
|
|
Hold
Downgraded
| $0.5000 |
30%
upside
| 1 | -41% |
–
| 30 Dec ‘25 9 days ago |
|
|
|
Buy
Maintained
| $134 |
28%
upside
| 1 | +6.3% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $21 |
37%
upside
| 1 | +9.9% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $1.60 |
17%
upside
| 1 | – |
–
| 31 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $549 |
37%
upside
| 2 | +14% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $7 |
8%
upside
| 1 | – |
–
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Initiated
| $15 |
44%
downside
| 1 | +179% |
0
%
| 22 Sep ‘25 3 months ago |
|
|
|
Hold
Initiated
| $3.50 |
10%
upside
| 1 | – |
–
| 24 Jun ‘25 6 months ago |
|
|
|
Buy
Maintained
| $53 |
534%
upside
| 1 | +23% |
0
%
| 11 Mar ‘25 10 months ago |
|
|
|
Hold
Downgraded
| $8.50 |
0%
downside
| 1 | – |
–
| 5 Mar ‘25 10 months ago |
|
|
|
Buy
Maintained
| $8 |
55%
upside
| 1 | +48% |
0
%
| 10 Feb ‘25 11 months ago |
|